Clinical Efficacy and Safety of Malarone®, Azithromycin and Artesunate Combination for Treatment of Babesia gibsoni in Naturally Infected Dogs
Authors:
- Martina KarasováMartina Karasová
- Csilla TóthováCTCsilla Tóthová
- Bronislava VíchováBronislava Víchová
- Lucia BlaňarováLBLucia Blaňarová
- Terézia KiskováTerézia Kisková
- Simona GrelováSGSimona Grelová
- Radka StaroňováRSRadka Staroňová
- Alena MicháľováAMAlena Micháľová
- Martin KožárMKMartin Kožár
- Oskar NagyONOskar Nagy
- Mária FialkovičováMFMária Fialkovičová
Open Access
Abstract
Babesia gibsoni is a tick-borne protozoal blood parasite that may cause hemolytic anemia, thrombocytopenia, lethargy, and/or splenomegaly in dogs. Many drugs have been used in management of canine babesiosis such as monotherapy or combined treatment, including diminazene aceturate, imidocarb dipropionate, atovaquone, and antibiotics. This report examines the effectiveness and safety of Malarone®, azithromycin (AZM) and artesunate (ART) combination for the treatment of babesiosis in dogs naturally infected with Babesia gibsoni. Twelve American Pit Bull Terriers were included in the experiment. Examined dogs underwent clinical and laboratory analysis including hematology and biochemistry profile and serum protein electrophoresis. After diagnosis, the dogs received combined therapy with Malarone® (13.5 mg/kg PO q24 h), azithromycin (10 mg/kg PO q24 h) and artesunate (12.5 mg/kg PO q24 h) for 10 days. The combined treatment improved hematology and biochemical parameters to the reference range gradually during the first 14 days already, resulting in the stable values until day 56 after treatment. No clinically apparent adverse effects were reported during treatment and monitoring. No relapses of parasitemia were detected in control days 180, 360, 540 and 720 in all dogs. Results of the study indicate that the combined treatment leads to successful elimination of parasitemia in chronically infected dogs with B. gibsoni.Keywords
Funding Information
- Ministry of Education, Science, Search and Sport of the Slovak Republic (VEGA 1/0177/22, VEGA 1/0314/20, VEGA 2/0014/21, VEGA 1/0658/20)
This publication has 52 references indexed in Scilit:
- Evaluation of azithromycin in systemic and toothpaste forms for the treatment of ciclosporin‐associated gingival overgrowth in dogsVeterinary Dermatology, 2013
- Answers to some common questions on serum protein electrophoresisVeterinary Record, 2011
- General Pharmacology of Artesunate, a Commonly used Antimalarial Drug: Effects on Central Nervous, Cardiovascular, and Respiratory SystemToxicological Research, 2010
- Use of a doxycycline-enrofloxacin-metronidazole combination with/without diminazene diaceturate to treat naturally occurring canine babesiosis caused by Babesia gibsoniActa Veterinaria Scandinavica, 2010
- Possible Emergence of Drug-Resistant Variants of Babesia gibsoni in Clinical Cases Treated with Atovaquone and AzithromycinJournal of Veterinary Internal Medicine, 2009
- Artesunate: developmental toxicity and toxicokinetics in monkeysBirth Defects Research Part B: Developmental and Reproductive Toxicology, 2008
- Blood, Bull Terriers and Babesiosis: further evidence for direct transmission of Babesia gibsoni in dogsAustralian Veterinary Journal, 2007
- Efficacy of Combined Atovaquone and Azithromycin for Therapy of Chronic Babesia gibsoni (Asian Genotype) Infections in DogsJournal of Veterinary Internal Medicine, 2004
- Efficacy of Combined Atovaquone and Azithromycin for Therapy of Chronic Babesia gibsoni (Asian Genotype) Infections in DogsJournal of Veterinary Internal Medicine, 2004
- Gapped BLAST and PSI-BLAST: a new generation of protein database search programsNucleic Acids Research, 1997